Literature DB >> 18330745

[Adaptation, validity, and reliability of the Metacognition Questionnaire-30 for the Turkish population, and its relationship to anxiety and obsessive-compulsive symptoms].

Ahmet Tosun1, Metehan Irak.   

Abstract

OBJECTIVE: The present study aimed to evaluate the psychometric properties of the short form of the Metacognition Questionnaire (MCQ-30) in a population of Turkish university students. The metacognitions questionnaire (MCQ) measures individual differences in a selection of metacognitive beliefs, judgments, and monitoring tendencies considered important in the metacognitive model of psychological disorders.
METHOD: The study included 850 university students from 15 Turkish universities. Mean age age of the participants was 21.22 years, 282 (33.17%) were female, and 568 (66.82%) were male.
RESULTS: Construct validity was evaluated by exploratory and confirmatory factor analysis (CFA). Exploratory factor analysis revealed that the Turkish version of MCQ-30 has 5 components, which is same factor structure as the original form. In addition, the fit indices of CFA suggested an acceptable fit to a 5-factor model consistent with the original MCQ-30. The Turkish MCQ-30 showed acceptable to good test-retest reliability, internal consistency, and convergent validity. Significant positive relationships between the subscales of MCQ-30 and measures of anxiety and obsessive-compulsive symptoms provided further support for the convergent validity of the Turkish version. Moreover, significant negative correlations were observed between age and the MCQ-30 subscales, and the effect of gender was significant on some of the subscales.
CONCLUSION: The psychometric properties of the Turkish version of MCQ-30 showed that the instrument is a valuable additional tool for the assessment of metacognition in Turkey.

Entities:  

Mesh:

Year:  2008        PMID: 18330745

Source DB:  PubMed          Journal:  Turk Psikiyatri Derg        ISSN: 1300-2163


  8 in total

1.  A Survey Focusing on Lucid Dreaming, Metacognition, and Dream Anxiety in Medical Students.

Authors:  Çağdaş Yokuşoğlu; Mücahit Atasoy; Nurgül Tekeli; Ahmet Ural; Çağla Ulus; Yunus Taylan; Gülser Aydin; Gözde Gültekin; Murat Emül
Journal:  Noro Psikiyatr Ars       Date:  2016-09-01       Impact factor: 1.339

2.  Metacognitive Beliefs and Their Relation with Symptoms in Obsessive-Compulsive Disorder.

Authors:  Selim Tümkaya; Filiz Karadağ; Ezgi Hanci Yenigün; Osman Özdel; Himani Kashyap
Journal:  Noro Psikiyatr Ars       Date:  2018-11-20       Impact factor: 1.339

3.  Validation of the French version of the « Meta-Cognition Questionnaire » for adolescents (MCQ-Af): Evolution of metacognitive beliefs with age and their links with anxiety during adolescence.

Authors:  Yasmina Lachat Shakeshaft; Thierry Lecerf; Larisa Morosan; Deborah Myriam Badoud; Martin Debbané
Journal:  PLoS One       Date:  2020-03-11       Impact factor: 3.240

4.  Metacognitions and brooding predict depressive symptoms in a community adolescent sample.

Authors:  Helene Pedersen; Ingrid Grønnæss; Mons Bendixen; Roger Hagen; Leif Edward Ottesen Kennair
Journal:  BMC Psychiatry       Date:  2022-03-01       Impact factor: 3.630

5.  Association between Metacognitive Beliefs and COVID-19 phobia in a community population: a cross-sectional study.

Authors:  Tuğba Ay; Feride Gökben Hizli Sayar
Journal:  Curr Psychol       Date:  2022-07-01

6.  COVID-19 associated psychological symptoms in Turkish population: A path model.

Authors:  Ayşegül Durak Batıgün; İpek Şenkal Ertürk
Journal:  Curr Psychol       Date:  2021-07-01

7.  Differences between autogenous and reactive obsessions in terms of metacognitions and automatic thoughts.

Authors:  İlkay Keleş Altun; Emel Uysal; Evrim Özkorumak Karagüzel
Journal:  Neuropsychiatr Dis Treat       Date:  2017-12-12       Impact factor: 2.570

8.  Joint contributions of metacognition and self-beliefs to uncertainty-guided checking behavior.

Authors:  Axel Baptista; Maxime Maheu; Luc Mallet; Karim N'Diaye
Journal:  Sci Rep       Date:  2021-09-24       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.